Understand the source comparison
Best Peptides for Receding Hairline: Mechanism Comparison
GHK-Cu (Copper Tripeptide) Stimulates dermal papilla proliferation, increases VEGF expression Topical (requires <500 Da molecular weight formulation) Strong. 6/8 RCTs positive, mean 12–17% density increase at 12–16 weeks 1.0–1.5mM concentration, twice daily Be
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHK-Cu (Copper Tripeptide)
- Stimulates dermal papilla proliferation, increases VEGF expression
- Topical (requires <500 Da molecular weight formulation)
- Strong. 6/8 RCTs positive, mean 12–17% density increase at 12–16 weeks
- 1.0–1.5mM concentration, twice daily
- Best-supported peptide for androgenetic alopecia; reproducible efficacy in peer-reviewed trials
- Thymosin Beta-4 (TB-4)
- Activates follicle stem cell migration from bulge to dermal papilla
- Subcutaneous injection (cannot penetrate topically)
- Moderate. Strong preclinical data, limited human case series
- 2–5mg weekly, 8–12 weeks
- Promising mechanism but requires injection; not practical for most users
- Valproyl Tripeptide-1 (Capixyl)
- Reduces androgen receptor sensitivity to DHT at follicle level
- Topical
- Weak. Single manufacturer-funded trial, no independent replication
- 4% concentration, twice daily
- Plausible mechanism but insufficient third-party validation; treat claims cautiously
- Biotinoyl Tripeptide-1
- Claimed to improve follicle anchoring and reduce telogen shedding
- Minimal. In vitro data only, no human RCTs
- Varies by formulation
- No clinical evidence base; avoid products making efficacy claims based solely on this peptide